Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Agile Therapeutics, Inc. (AGRX)

0.5959   -0.021 (-3.39%) 08-08 00:04
Open: 0.6 Pre. Close: 0.6168
High: 0.618 Low: 0.5601
Volume: 3,591,131 Market Cap: 19(M)
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.62 - 0.62 0.62 - 0.62
Low: 0.55 - 0.56 0.56 - 0.56
Close: 0.59 - 0.6 0.6 - 0.6

Technical analysis

as of: 2022-08-05 4:20:01 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 0.79     One year: 0.93
Support: Support1: 0.48    Support2: 0.4
Resistance: Resistance1: 0.67    Resistance2: 0.79
Pivot: 0.55
Moving Average: MA(5): 0.57     MA(20): 0.57
MA(100): 3.01     MA(250): 16.82
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 74.3     %D(3): 56.4
RSI: RSI(14): 42.2
52-week: High: 50.4  Low: 0.48
Average Vol(K): 3-Month: 10,882 (K)  10-Days: 4,252 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ AGRX ] has closed below upper band by 20.4%. Bollinger Bands are 94.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 04 Aug 2022
Agile Therapeutics (AGRX) Scheduled to Post Quarterly Earnings on Thursday - Defense World

Thu, 28 Jul 2022
Agile Therapeutics, Inc. (NASDAQ:AGRX) Sees Large Decrease in Short Interest - Defense World

Wed, 13 Jul 2022
Circling Back On Agile Therapeutics Stock (NASDAQ:AGRX) - Seeking Alpha

Fri, 08 Jul 2022
What is Wall Street's Target Price for Agile Therapeutics Inc (AGRX) Stock Friday? - InvestorsObserver

Fri, 01 Jul 2022
Agile Therapeutics prices $24M upsized stock offering (NASDAQ:AGRX) - Seeking Alpha

Tue, 28 Jun 2022
Healthcare Breakthroughs: KZR, NMLSF, AGRX, LMLLF Report Latest Advances in Novel Therapeutics for Inflammatory Diseases, Oncology, and Autism - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. -43 (M)
Shares Float 0 (M)
% Held by Insiders 3.151e+007 (%)
% Held by Institutions 4.17e+006 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -6.62e+006
EPS Est Next Qtl -0.26
EPS Est This Year -1.02
EPS Est Next Year -0.99
Book Value (p.s.) -26.17
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 224.4
Return on Equity (ttm) -99.1
Qtrly Rev. Growth 5.75e+006
Gross Profit (p.s.) 91.98
Sales Per Share -230.28
EBITDA (p.s.) -5.96396e+006
Qtrly Earnings Growth -6.809e+007
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value -0.03
Price to Sales -0.01
Price to Cash Flow 0

Stock Dividends

Dividend 2.94e+006
Forward Dividend 502610
Dividend Yield 493371000%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.